Drug regulatory systems must foster innovation

Science

Volumn 332, Issue 6026, 2011, Pages 174-175

  Schellekens, Huub ^a,b   Moors, Ellen ^b   Leufkens, H G ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MEDICINES EVALUATION BOARD   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CONTROL; DRUG RESEARCH; DRUG SCREENING; FUNDING; GOVERNMENT REGULATION; LETTER; MEDICAL RESEARCH; PATIENT SAFETY; PRIORITY JOURNAL; SCIENCE; TECHNOLOGY;

DIFFUSION OF INNOVATION; DRUG AND NARCOTIC CONTROL; DRUG DISCOVERY; UNITED STATES;

EID: 79953807078     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.332.6026.174     Document Type: Letter

References (3)

1. T. J. Giezen et al., JAMA 300, 1887 (2008).
2. H. G. Eichler, F. Pignatti, B. Flamion, H. G. Leufkens, A. Breckenridge, Nat. Rev. Drug Discov. 7, 818 (2008).
3. H. Schellekens, E. Moors, Nat. Biotechnol. 28, 28 (2010).